glutathione in ovarian cancer a double-edged sword Role of SLC7A11/xCT Frontiers | Metabolic reprogramming of
Frontiers Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy Glutathione: Lights and Shadows in Cancer Patients Frontiers The strategic breakdown: CHAC enzymes as regulators of glutathione homeostasis and disease implications Impact of the glutathione synthesis pathway on sulfasalazine treated endometrial cancer Oncotarget
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



